Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Abstract Text:

    rebecca m shepherdRebecca M Shepherd,benjamin j capocciaBenjamin J Capoccia,steven m devineSteven M Devine,john dipersioJohn Dipersio,kathryn m trinkausKathryn M Trinkaus,david ingramDavid Ingram,daniel c linkDaniel C Link,

    Circulating endothelial progenitor cells (EPCs) are thought to contribute to angiogenesis following vascular injury, stimulating interest in their ability to mediate therapeutic angiogenesis. However, the number of EPCs in the blood is low, limiting endogenous repair, and a method to rapidly mobilize EPCs has not been reported. In this study, healthy donors were mobilized sequentially with the CXCR4 antagonist, AMD3100, and G-CSF. The number of EPCs and circulating angiogenic cells (CACs) in the blood and pheresis product was determined and the angiogenic capacity of each cell population assessed. Compared with baseline, treatment with AMD3100 or G-CSF increased the number of blood CACs 10.0-fold +/- 4.4-fold and 8.8-fold +/- 3.7-fold, respectively. The number of EPCs in the blood increased 10.2-fold +/- 3.3-fold and 21.8-fold +/- 5.4-fold, respectively. On a percell basis, CACs harvested from G-CSF-mobilized blood displayed increased in vivo angiogenic potential compared with AMD3100-mobilized CACs. Mobilized EPCs displayed a greater proliferative capacity than EPCs isolated from baseline blood. Both CACs and EPCs were efficiently harvested by leukapheresis. Cryopreserved CACs but not EPCs retained functional activity after thawing. These data show that AMD3100 is a potent and rapid mobilizer of angiogenic cells and demonstrate the feasibility of obtaining and storing large numbers of angiogenic cells by leukapheresis.

    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Publishing Authors By Initials

    rm shepherdRM Shepherd,bj capocciaBJ Capoccia,sm devineSM Devine,j dipersioJ Dipersio,km trinkausKM Trinkaus,d ingramD Ingram,dc linkDC Link,

    For similar cells: stem cells research abstracts see: cells: stem cells research

    PUBMED ID PMID:

    MEDLINE DATE:

    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Blood

    VOLUME: 108

    Page Numbers: 3662-7

    Journal Abbreviation: Blood

    ISSN: 0006-4971

    DAY: 15

    MONTH: 08

    YEAR: 2006

    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7603509

    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Keywords Mesh Terms:

    KEYWORDS: Stem Cells

    MESH TERMS: physiology

    Chemical & Substance for Abstract: Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Information

    Substance Name: JM 3100

    Registry Number: 155148-31-5

    Grant and Affiliation Information for Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

    AFFILIATION: Division of Oncology, Department of Medicine, 660 S Euclid Ave, Campus Box 8007, Saint Louis, MO 63110, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NHLBI

    GRANT: T32 HL 07088-23

    ACRONYM: HL

    MEDLINETA: Blood

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News